Angelis Oncology
San Francisco, US · Founded 2026
Biotech
Founders & leadership
DS
Daniel SantiPresident; Chief Executive Officer; Secretary; Treasurer
Reported raises · per SEC filings
Form D private placements$400KraisedJul 2026 · 1 investors · Biotechnology
Rule 506(b)Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.